Tag - medicine

 
 

MEDICINE

Japan Times
JAPAN
Jan 13, 2023
Hospital given COVID-19 aid refused to accept patient, Japan auditor says
In response to the board's inquiry, one hospital explained that it had to refuse a patient for a bed because of a shortage of nurses.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
EDITORIALS
Jan 13, 2023
Health concerns, not pride, should guide COVID-19 travel policy
Apparently China can shut its borders to reduce the risk of COVID-19 infections, but Beijing doesn't think other countries should do the same.
Japan Times
COMMENTARY / World
Jan 12, 2023
Why the future of technology is so hard to predict
It's 2023, yet we're not all riding Segways, having sex with robots or cloning humans. What gives?
Japan Times
COMMENTARY / World
Jan 11, 2023
Don't write off the retooled COVID-19 boosters
Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.
Japan Times
JAPAN
Jan 11, 2023
Health ministry suggests restricting bulk drug purchases amid hoarding fears
The message follows reports of Chinese people in the country buying medicine in bulk and mailing it to friends and families back home.
Japan Times
BUSINESS / Markets
Jan 10, 2023
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.
Japan Times
ASIA PACIFIC
Jan 7, 2023
China’s COVID surge threatens villages as Lunar New Year approaches
China is bracing for an onslaught of infections in its fragile countryside as millions of people crowd onto trains and buses to return to their rural homes for the Lunar New Year holiday.
Japan Times
ASIA PACIFIC / Science & Health
Jan 7, 2023
China in talks with Pfizer for generic COVID drug
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.
Japan Times
COMMENTARY / World
Jan 6, 2023
No, vaccines aren’t making new COVID-19 variants worse
The omicron sequel XBB.1.5 is driving a new wave of COVID-19 infections — and misinformation.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
WORLD
Dec 30, 2022
Dressing 'revolution' seeks artificial skin for burn victims
New developments have shaken up the world of wound healing, long a neglected area of medical research.
Japan Times
ASIA PACIFIC
Dec 30, 2022
China's COVID wave sparks scramble for vital drugs across Asia
Beijing's decision to abruptly remove most pandemic restrictions with little preparation is driving an unprecedented number of cases, leaving hospitals and funeral homes overwhelmed.
Japan Times
BUSINESS / Companies
Dec 28, 2022
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough
Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer's biomarkers in blood tests.
Japan Times
JAPAN
Dec 25, 2022
Doctor-staffed rapid response vehicles in wider use in Japan
By providing treatment to patients before they are taken to hospital, including in the vehicles, medical professionals can respond to sudden changes in their conditions.
Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer’s
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
WORLD / Science & Health
Dec 22, 2022
Injectable HIV treatment offers hope to Ugandan patients
Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.
Japan Times
COMMENTARY / World
Dec 21, 2022
Another Crispr first: New treatment wipes out teen's cancer
Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?